Rate My Professor Athirah Bakhtiar

Her research interests encompass medical nanotechnology, applying advanced delivery approaches with biodegradable and inorganic materials to enhance drug and gene therapy delivery to breast cancer cells in vitro and in vivo. She investigates non-communicable diseases such as diabetes mellitus, particularly oral insulin drug delivery, and conducts clinical studies on medication safety to promote safe prescribing and dispensing in healthcare organizations. Key publications include 'Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus' (2025, co-authors: Low, C. Y. et al.), 'Anticancer potential of synthetic costunolide and dehydrocostus lactone derivatives: A systematic review' (2025, co-authors: Amer, M. F. A., Hattab, D.), 'The potential of nanoparticle-based siRNA delivery in breast cancer treatment' (2025, co-authors: Kuan, X. Y., Chowdhury, E. H.), 'Evaluation of potential drug–drug interactions with medical cannabis' (2024, co-authors: Ho, J. J. Y. et al.), and 'Acceptability of COVID-19 booster vaccine in Malaysia: a cross-sectional study' (2024, co-authors: Khoo, C. M. J. et al.). She received Complementary Medicine Education certifications (Bronze, Silver, Gold, and Platinum) from 2019 to 2020 and delivered a keynote/plenary speech at the University of Nottingham Malaysia on 15 February 2023. Her work contributes to SDG 3 Good Health and Well-being.